Summary
This prediction ended on 10.12.23 with a price of €30.20. During the runtime of the prediction for Genmab As the price only changed by 0.67%. melinda has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Genmab As | 1.504% | 1.504% | 39.175% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |